167 related articles for article (PubMed ID: 33667713)
1. Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.
Kato T; Murata D; Anders RA; Sesaki H; Iijima M
Biochem Biophys Res Commun; 2021 Apr; 549():83-90. PubMed ID: 33667713
[TBL] [Abstract][Full Text] [Related]
2. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression.
Chang CJ; Mulholland DJ; Valamehr B; Mosessian S; Sellers WR; Wu H
Mol Cell Biol; 2008 May; 28(10):3281-9. PubMed ID: 18332125
[TBL] [Abstract][Full Text] [Related]
3. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
[TBL] [Abstract][Full Text] [Related]
4. Transformation of SOX9
Chen J; Debebe A; Zeng N; Kopp J; He L; Sander M; Stiles BL
Sci Rep; 2021 Jun; 11(1):11823. PubMed ID: 34083580
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53.
He X; Ni Y; Wang Y; Romigh T; Eng C
Hum Mol Genet; 2011 Jan; 20(1):80-9. PubMed ID: 20926450
[TBL] [Abstract][Full Text] [Related]
6. Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Wang Y; Hong Y; Li M; Long J; Zhao YP; Zhang JX; Li Q; You H; Tong WM; Jia JD; Huang J
PLoS One; 2013; 8(12):e82426. PubMed ID: 24349281
[TBL] [Abstract][Full Text] [Related]
7. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
8. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
[TBL] [Abstract][Full Text] [Related]
9. PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress.
Wu Y; Zhou H; Wu K; Lee S; Li R; Liu X
Antioxid Redox Signal; 2014 Mar; 20(9):1382-95. PubMed ID: 24063548
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
[TBL] [Abstract][Full Text] [Related]
11. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.
Xu X; Kobayashi S; Qiao W; Li C; Xiao C; Radaeva S; Stiles B; Wang RH; Ohara N; Yoshino T; LeRoith D; Torbenson MS; Gores GJ; Wu H; Gao B; Deng CX
J Clin Invest; 2006 Jul; 116(7):1843-52. PubMed ID: 16767220
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGB1 in hepatocytes accelerates PTEN inactivation-induced liver cancer.
Athavale D; Barahona I; Song Z; Desert R; Chen W; Han H; Das S; Ge X; Komakula SSB; Gao S; Lantvit D; Guzman G; Nieto N
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055645
[TBL] [Abstract][Full Text] [Related]
13. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.
Chen WT; Zhu G; Pfaffenbach K; Kanel G; Stiles B; Lee AS
Oncogene; 2014 Oct; 33(42):4997-5005. PubMed ID: 24141775
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53-progerin interaction.
Luo X; Jiang X; Li J; Bai Y; Li Z; Wei P; Sun S; Liang Y; Han S; Li X; Zhang B
Cell Death Dis; 2019 Jun; 10(6):451. PubMed ID: 31171766
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression.
Özdemir BH
Exp Clin Transplant; 2023 Apr; 21(4):291-298. PubMed ID: 35297332
[TBL] [Abstract][Full Text] [Related]
16. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
17. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
Lu D; Han C; Wu T
Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
[TBL] [Abstract][Full Text] [Related]
18. Role of PTEN in Oxidative Stress and DNA Damage in the Liver of Whole-Body Pten Haplodeficient Mice.
Bankoglu EE; Tschopp O; Schmitt J; Burkard P; Jahn D; Geier A; Stopper H
PLoS One; 2016; 11(11):e0166956. PubMed ID: 27893783
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into maintenance of high p53 acetylation by PTEN.
Li AG; Piluso LG; Cai X; Wei G; Sellers WR; Liu X
Mol Cell; 2006 Aug; 23(4):575-87. PubMed ID: 16916644
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
